Throwback to #PancreasClub Honored to present PANC-PALS Collaborator-led consortium and global registry 💪🏻💪🏻 Thank you for everyone’s hard work to get IRBs and contracts signed 📈🧑‍💻 @ammaraj.bsky.social

What a pleasure to host University of Padova PANC-PALS local PI, @gio-marchegiani.bsky.social, at our HQ this week! 💜 Great discussions followed by a drink by the East River 😎 #PANCPALS @ammaraj.bsky.social

Thank you all! Great seeing #PANCPALS group at #PancreasClub 💪🏻💜 @ammaraj.bsky.social

Drop by our #PANCPALS booth at #PancreasClub this weekend, and get your lanyard! 🙌🏻 💜 @ammaraj.bsky.social

PANC-PALS / NYU Langone Health at the #PanCANPurpleStride NYC this past Saturday! 💜☔️ @pancan.bsky.social @ammaraj.bsky.social

Neoadjuvant chemo 🤜🤛 surgery for Resectable PDAC 🇯🇵 RCT 💉 Gemcitabine + S1 median OS 37 months vs. 26 💡 Is neoadjuvant chemo extending survival over upfront surgery?! 🤔 What are your thoughts?! 💭 journals.lww.com/annalsofsurg... #HPBSky #Surgsky

🚨New publication! 🚨 A new method for evaluating CA19-9 during neoadjuvant therapy, and its role in predicting overall and disease-free survival in BR-PC. A way towards personalised prognostication! 💜💪🏻🙏🏼 doi.org/10.1097/SLA....

Staying hydrated everywhere with our #PANCPALS waterbottle 🌊💪🏻 Progressing with contracts, and looking forward to our Azure platform… soon to be ready 👩🏼‍💻🧑🏽‍💻 Stay tuned for updates! 💜🤓 @ammaraj.bsky.social

We are honored to see the #PANCPALS consortium expanding the last few weeks! Already over 80 committed sites globally, and still growing 💪👀 Join us now! Find the joining questionnaire on pancpals.com/joining-ques... @ammaraj.bsky.social @marcbesselink.bsky.social

👁️ Bordeline observable IPMNs 👁️ our new editorial in @bmj.com GUT ⚖️ Reappraisal of the actual benefit of extended surveillance between cancer risk🫸 🫷discontinuation 🧬 "Less invasive" biomarkers are expected to exclude from FU harmless cyst since first observation 🟠 gut.bmj.com/content/earl...

Very honored that PANC-PALS founder and consortium coordinator @ammaraj.bsky.social was able to introduce the consortium at the #AHPBA this morning #LeveragingLargeDatabases. Followed by an excellent expert panel discussion. 💪🏻 🩺 Thanks everyone! #AHPBA2025 #PANCPALS 💜

Together 💪🏻💜 #PANCPALS #AHPBA2025 @ammaraj.bsky.social @marcbesselink.bsky.social

More of the PANC-PALS team at our #AHPBA booth! 💜 #PANCPALS #AHPBA2025 @ammaraj.bsky.social

#PANCPALS you rock! 🎸

Can we personalize 📐 surveillance of IPMN?! 🇮🇹 🇺🇸 🇩🇪 🇰🇷 🇳🇱 🇬🇧 🇸🇬 🇪🇸 analysis of 2k IPMN developing WF/HRS 👴 Age and 🫧 cyst size impact the timing of surveillance 🦘 First prudential control always 6 months… then 🦘🦘 2 years if no WF/HRS journals.lww.com/annalsofsurg... #HPBSky #SurgSky

Congrats to #AnoukEmmen and @tfstoop.bsky.social for excellent presentations in the #PresidentialSession #AHPBA2025 AHPBA Miami 🇺🇸: #DIPLOMA2 RCT🇪🇺 robot/lap 🤖 vs open Whipple and #PREOPANC4🇳🇱 implementation of surgery for locally advanced #PancreaticCancer for @dpcgofficial.bsky.social and #EMIPS

Come find us at our booth at #AHPBA ! 💜🌞 @ammaraj.bsky.social @marcbesselink.bsky.social

Published in #hpbjournal, 🌎 survey on surgical management of pancreatic neck/body cancer with venous involvement: 📝222 surgeons, 49 countries, 6 continents 📍Heterogeneity in surgical management➡️particularly when ⬆️ venous involvement ⚠️ Need for research 🔍 @eahpba.bsky.social @ihpba.bsky.social

Delayed Gastric Emptying 🤢 is an issue after robotic 🤖 PD 2️⃣1️⃣ % overall DGE rate 📹 assessment of technical skills ⬇️ DGE rates (after 35 procedures) 🤔 How do you perform GJ after a robotic PD ?! How do you prevent DGE?! 🫵 journals.lww.com/annalsofsurg... @marcbesselink.bsky.social #HPBSky

Preperations underway for the #AHPBA Miami 2025 at the PANC-PALS HQ! 🙌🏻📂 Come visit us at our booth! #AHPBA #PANCPALS @ammaraj.bsky.social

Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?! 🌎 1k resected only 7% after NAT 👍 BR / LAPC no worse OS after NAT 🧪 CA19.9 indicates “biological” treatment effect 👉https://journals.lww.com/annalsofsurgery/abstract/9900/neoadjuvant_chemotherapy_for_intraductal_papillary.1220.aspx

Meet our team! #PANCPALS Meet Dr. Camila Hidalgo Salinas, founder & a consortium coordinator. Dr. Hidalgo Salinas is a Postdoctoral Research Fellow at #NYULangoneHealth #Surgery She says that with PANC-PALS "We envision a new era of pancreatic cancer research through global collaboration."

A wonderful nationwide collaboration with help of some of our expert friends in 🇺🇸 🇩🇪 !!

Failure to Rescue After Resection of Perhilar Cholangiocarcinoma in an International Multicenter Cohort ⁦‪@AnnSurgOncol‬⁩ link.springer.com/article/10.1...

Can #Video Grading of Bile Duct Anastomoses During Robotic 🤖 #Pancreatoduodenectomy Predicts Bile Leak (BL)? ✅ Videos from 259 pts robotic HJ: 6.9% B/C BL ✅ OSATS score <21 assoc with BL ✅ The rate of BL was 5.1% for OSATS>21 vs 12.5% for OSATS ≤21 ▶️ journals.lww.com/annalsofsurg...

In #BMC Cancer, #PREOPANC4 protocol to improve #LAPC care in 🇳🇱 @dpcgofficial.bsky.social with help of 4 international experts🇩🇪🇺🇸: 📎Multidisciplinary & surgical training program 📎Structured induction therapy, response evaluation & selection for surgery 📎National expertpanel 📎Patient-centered care

🧪 CA19.9 response after induction FOLFIRINOX for LAPC @bjsurgery.bsky.social 1k LAPC chemo ➡️ restaging 23% M1 😢 24% underwent surgery 🪡 📉 Baseline CA19.9 Not predictor of survival 📈 CA19.9 after induction / decrease 80% best survival academic.oup.com/bjs/article/... @bjsacademy.bsky.social

Meet our team! #PANCPALS Meet Dr. Ammar Javed, the founder & a consortium coordinator. Dr. Javed is an assistant professor at #NYULangoneHealth #Surgery. He believes that via PANC-PALS "Together, we can transform pancreatic cancer research through global collaboration." @ammaraj.bsky.social

Come visit our booth at the #AHPBA March 20-23! 🌞 @ammaraj.bsky.social

How do costs of #robot 🤖 vs open #pancreatoduodenectomy compare? 588 pts A’dam🇳🇱 (214 RPD, 374 OPD) ⛔️Costs €4,804 ⬆️ RPD ✅As outcomes RPD improved in the 2nd half: cost per RPD €11,058 less 🔑 Costs in the 2nd half RPD vs OPD comparable (€21,778 vs. €21,013) ▶️ journals.lww.com/annalsofsurg...

Prognostic factors 🔮 in resected pancreatic cancer: personalized model according to neoadjuvant chemo 🇺🇸🇳🇱 2.7k PDAC / 20% after NAT 💉 NAT negative predictors are 🧪 non normalized CA 19.9 / 🍒 N+ / 🧊 grade treatment response journals.lww.com/annalsofsurg... #HPBSky #SurgSky

What are the prognostic factors in patients with resected #PDAC that receive NAT? 💊🏥 #PANCPALS published last week in Annals of Surgery! Key: prognostic factors for OS differ between chemo-naive and NAT patients. Find the prognostic tool on our website soon! 💪 @ammaraj.bsky.social